Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.97 |
| ▸ | LMNA | P02545 | 1/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.97 |
| ▸ | MEN1 | O00255 | 3/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.76 |
| ▸ | ABCG2 | Q9UNQ0 | 9/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.43 |
| ▸ | NMT2 | O60551 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cromolyn SCHEMBL318268 | 1.00 | GPR35 (0.97) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL29352570 | 0.99 | GPR35 (1.00) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL3865 | 0.99 | GPR35 (1.00) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL29353205 | 0.99 | GPR35 (1.00) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL8662365 | 0.97 | GPR35 (0.97) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL4108171 | 0.97 | GPR35 (0.97) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL11253121 | 0.95 | GPR35 (0.93) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL2717434 | 0.93 | GPR35 (0.88) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL11175797 | 0.93 | GPR35 (0.88) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL11832140 | 0.93 | GPR35 (0.88) | GPR35LMNATDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15841 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| US-12616803-B2 | Apparatus for dispensing inhalant medicament | METOPI PHARMACEUTICALS, INC. (US) | 2026-05-05 | — | — | US | claimed |
| WO-2026090557-A1 | SYSTEMS AND METHODS FOR PROCESSING ISM AND MCAS CLINICAL TRIAL DATA | TELIOS PHARMA INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-20260108514-A1 | METHOD OF INHIBITING EPITHELIAL-MESENCHYMAL TRANSITION AND CANCER METASTASIS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2026-04-23 | — | — | US | claimed |
| US-12605471-B2 | Cromolyn derivatives and related methods of imaging and treatment | THE GENERAL HOSPITAL CORPORATION (US) | 2026-04-21 | — | — | US | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| EP-4687912-A1 | GENOTYPE-SPECIFIC METHODS AND SYSTEMS FOR TREATMENT OF NEURODEGENERATIVE DISEASE | Phenonet, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-12545948-B2 | Identification of novel loci in asthma and methods of use thereof for the diagnosis and treatment of asthma | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-02-10 | — | — | US | claimed |
| US-20260026967-A1 | MATERIALS AND METHODS FOR PUNCTAL PLUGS | GLAUKOS CORP (US) | 2026-01-29 | — | — | US | claimed |
| EP-4676500-A2 | MICROBIAL CONSORTIA | Kanvas Biosciences, Inc (US) | 2026-01-14 | — | — | EP | claimed |
| WO-1990006775-A1 | A NOVEL NONPHOSPHOLIPID LIPOSOME COMPOSITION FOR SUSTAINED RELEASE OF DRUGS | LIPOSOME TECHNOLOGY, INC. (US) | 1990-06-28 | — | — | WO | claimed |
| US-4895719-A | SUSPENSION, ENCAPSULATION, DRUG DELIVERY | LIPOSOME TECHNOLOGY, INC. (US) | 1990-01-23 | — | — | US | claimed |
| US-4882170-A | Method of treatment | FISONS CORPORATION (US) | 1989-11-21 | — | — | US | claimed |
| EP-0223831-A4 | LIPOSOME INHALATION METHOD AND SYSTEM. | LIPOSOME TECHNOLOGY INC (US) | 1987-10-12 | — | — | EP | claimed |
| EP-0223831-A1 | LIPOSOME INHALATION METHOD AND SYSTEM. | LIPOSOME TECHNOLOGY INC (US) | 1987-06-03 | — | — | EP | claimed |
| WO-1986006959-A1 | LIPOSOME INHALATION METHOD AND SYSTEM | LIPOSOME TECHNOLOGY, INC. (US) | 1986-12-04 | — | — | WO | claimed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| US-4269835-A | Nasal composition for relieving nasal distress | WHITTLE BARRY J | 1981-05-26 | — | — | US | claimed |
| US-4161516-A | PELLET OR GRANULAR, ADAPTED TO BE FLUIDIZE AND USED AS INHALANT | FISONS LIMITED (GB) | 1979-07-17 | — | — | US | claimed |